National Science day special
Dr L Boominathan PhD
In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Molecular insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor RECK via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
To cite: Boominathan, Insights into Molecular cancer therapy: NOS-2 suppresses the expression of RECK tumor suppressor via up regulation of its target gene, 28/February/2014, 9.05 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org